Boundless Bio, Inc. (BOLD) stock
BOLDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.46+0.00 (0.00%)
Close on Nov 12, 2026Market cap $55.96MP/E –Yield –
Boundless Bio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Boundless Bio's enterprise value was -$17.31M on Nov 11, 2026, against -$91.41M a year earlier. Over the last 3 years it ranged from -$121.30M to -$9.45M, with a median of -$99.57M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$17.31M | – |
| 2025 | Dec 31, 2025 | -$90.74M | – |
| 2024 | Dec 31, 2024 | -$102.56M | – |
See a number that looks wrong?